stacking retatrutide and tirzepatide terzepatide for weight loss? STOP Combining Retatrutide and Tirzepatide

A potentially higher occupational risk has been described for several other solid tumors (390)

Then injections only every 12 weeks

In TKI-pretreated patients, BMS drug elicited a 50% cORR, with a median response duration of 9.9 months

Where an alternative glucose lowering therapy needs to be considered, use the principles of shared decision making as per NICE guidelines Where there is reduced access to GLP-1 RAs, support people with type 2 diabetes to access to structured education and weight management programmes where available Order stocks sensibly in line with demand during this time, limiting prescribing to minimise risk to the supply chain whilst acknowledging the needs of the patient